Abstract
Alzheimer’s disease (AD) is the most common neurodegenerative disease characterized by the presence of senile plaques (SPs) and neurofibrillary tangles (NFTs) in the hippocampus and cortex of afflicted patients. In case of AD patients, during the progression of the disease, there is proof that brain tissues of these individuals are exposed to oxidative stress (OS). In AD, advanced glycation end products (AGEs) exist in amyloid plaques; moreover, accelerated oxidation of glycated proteins might cause its extracellular accumulation. AGEs have also found to take part in neuronal death, initiating production of free radical and therefore increasing OS. In case of progression of AD, emerging proof has shown that OS plays a key role. Nevertheless, the processes that ultimately cause disturbance of redox balance and also the sources of the free radicals are still unclear. Likewise, an excessive amount of reactive oxygen species (ROS) might be produced from processes including dysfunction of mitochondria and/or abnormal transition metal accumulation, though the redox imbalance seems to be promoted by the aberrant accumulation of amyloid ß (Aβ) and tau proteins. For Aβ- and tau-mediated neurotoxicity, the resulted OS has been associated. There is also the availability of evidence that OS might increase the aggregation and production of Aβ and also assist the polymerization as well as phosphorylation of tau, therefore creating a malicious cycle that stimulates the progression and even initiation of Alzheimer’s. This chapter represents the critical pathogenic mechanism of OS and AD.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD:
-
Alzheimer’s disease
- SPs:
-
senile plaques
- NFTs:
-
neurofibrillary tangles
- OS:
-
oxidative stress
References
Acevedo KM, Hung YH, Dalziel AH et al (2011) Copper promotes the trafficking of the amyloid precursor protein. J Biol Chem 286:8252–8262. https://doi.org/10.1074/jbc.M110.128512
Acevedo KM, Opazo CM, Norrish D et al (2014) phosphorylation of amyloid precursor protein at threonine 668 is essential for its copper-responsive trafficking in SH-SY5Y neuroblastoma cells. J Biol Chem 289:11007–11019. https://doi.org/10.1074/jbc.M113.538710
Anantharaman M, Tangpong J, Keller JN et al (2006) Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer’s disease. Am J Pathol 168:1608–1618
Ansari MA, Scheff SW (2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69:155–167. https://doi.org/10.1097/NEN.0b013e3181cb5af4
Apelt J, Bigl M, Wunderlich P, Schliebs R (2004) Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. Int J Dev Neurosci 22:475–484. https://doi.org/10.1016/j.ijdevneu.2004.07.006
Atwood CS, Moir RD, Huang X et al (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273:12817–12826
Barnham KJ, McKinstry WJ, Multhaup G et al (2003) Structure of the Alzheimer’s disease amyloid precursor protein copper binding domain. J Biol Chem 278:17401–17407. https://doi.org/10.1074/jbc.M300629200
Barone E, Di Domenico F, Sultana R et al (2012) Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med 52:2292–2301. https://doi.org/10.1016/j.freeradbiomed.2012.03.020
Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77:817–827
Bellingham SA, Ciccotosto GD, Needham BE et al (2004) Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts. J Neurochem 91:423–428. https://doi.org/10.1111/j.1471-4159.2004.02731.x
Berlett BS, Stadtman ER (1997) Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313–20316
Billings LM, Oddo S, Green KN et al (2005) Intraneuronal Aβ causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron 45:675–688. https://doi.org/10.1016/j.neuron.2005.01.040
Billingsley ML, Kincaid RL (1997) Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323(Pt 3):577–591
Bondy SC, Campbell A (2016) Inflammation, aging, and oxidative stress. Springer, New York
Bruce-Keller AJ, Li YJ, Lovell MA et al (1998) 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J Neuropathol Exp Neurol 57:257–267
Budimir A (2011) Metal ions, Alzheimer’s disease and chelation therapy. Acta Pharma 61:1–14. https://doi.org/10.2478/v10007-011-0006-6
Bush AI (2002) Metal complexing agents as therapies for Alzheimer’s disease. Neurobiol Aging 23:1031–1038
Bush AI (2003) The metallobiology of Alzheimer’s disease. Trends Neurosci 26:207–214. https://doi.org/10.1016/S0166-2236(03)00067-5
Bush AI, Pettingell WH, Multhaup G et al (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265:1464–1467
Casley CS, Canevari L, Land JM et al (2002) Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 80:91–100
Caspersen C, Wang N, Yao J et al (2005) Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s disease. FASEB J 19:2040–2041. https://doi.org/10.1096/fj.05-3735fje
Cente M, Filipcik P, Pevalova M, Novak M (2006) Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. Eur J Neurosci 24:1085–1090. https://doi.org/10.1111/j.1460-9568.2006.04986.x
Cente M, Filipcik P, Mandakova S et al (2009) Expression of a truncated human tau protein induces aqueous-phase free radicals in a rat model of tauopathy: implications for targeted antioxidative therapy. J Alzheimers Dis 17:913–920. https://doi.org/10.3233/JAD-2009-1107
Cheignon C, Tomas M, Bonnefont-Rousselot D et al (2018) Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol 14:450–464. https://doi.org/10.1016/j.redox.2017.10.014
Chen GC, Kong J (2012) Neural regeneration research. Elsevier (Singapore) Pte. Ltd, Singapore
Choi Y-G, Kim J-I, Lee H-P et al (2000) Induction of heme oxygenase-1 in the brains of scrapie-infected mice. Neurosci Lett 289:173–176. https://doi.org/10.1016/S0304-3940(00)01277-5
Colaco CA, Harrington CR (1994) Glycation: a pathological modification in neuropathies?: a hypothesis. Neuroreport 5:859–861
Cole GM, Teter B, Frautschy SA (2007) Neuroprotective effects of curcumin. In: The molecular targets and therapeutic uses of curcumin in health and disease. Springer, Boston, MA, pp 197–212
Collins AR, Dusinská M, Gedik CM, Stĕtina R (1996) Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect 104(Suppl 3):465–469. https://doi.org/10.1289/ehp.96104s3465
Curtain CC, Ali F, Volitakis I et al (2001) Alzheimer’s Disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem 276:20466–20473. https://doi.org/10.1074/jbc.M100175200
Dalle-Donne I, Aldini G, Carini M et al (2014) Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 10:389–406
David DC, Hauptmann S, Scherping I et al (2005) Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L Tau transgenic mice. J Biol Chem 280:23802–23814. https://doi.org/10.1074/jbc.M500356200
Davies MJ (2005) The oxidative environment and protein damage. Biochim Biophys Acta, Proteins Proteomics 1703:93–109. https://doi.org/10.1016/j.bbapap.2004.08.007
De Felice FG, Velasco PT, Lambert MP et al (2007) Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590–11601. https://doi.org/10.1074/jbc.M607483200
de la Monte SM, Wands JR (2006) Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer’s disease. J Alzheimers Dis 9:167–181
Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress. J Neurol Sci 143:137–142
Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB (2007) Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest 117:236–245. https://doi.org/10.1172/JCI28769
Duce JA, Bush AI, Adlard PA (2011) Role of amyloid-β–metal interactions in Alzheimer’s disease. Future Neurol 6:641–659. https://doi.org/10.2217/fnl.11.43
Dumont M, Wille E, Stack C et al (2009) Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer’s disease. FASEB J 23:2459–2466. https://doi.org/10.1096/fj.09-132928
Dumont M, Stack C, Elipenahli C et al (2011) Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice. FASEB J 25:4063–4072. https://doi.org/10.1096/fj.11-186650
Echtay K (2007) Mitochondrial uncoupling proteins--what is their physiological role? Free Radic Biol Med 43:1351–1371. https://doi.org/10.1016/j.freeradbiomed.2007.08.011
Eckert A, Schulz KL, Rhein V, Götz J (2010) Convergence of amyloid-β and tau pathologies on mitochondria in vivo. Mol Neurobiol 41:107–114. https://doi.org/10.1007/s12035-010-8109-5
Eckert A, Schmitt K, Götz J (2011) Mitochondrial dysfunction – the beginning of the end in Alzheimer’s disease? Separate and synergistic modes of tau and amyloid-β toxicity. Alzheimers Res Ther 3:15. https://doi.org/10.1186/alzrt74
Elipenahli C, Stack C, Jainuddin S et al (2012) Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice. J Alzheimers Dis 28:173–182. https://doi.org/10.3233/JAD-2011-111190
Emendato A, Milordini G, Zacco E et al (2018) Glycation affects fibril formation of Aβ peptides. J Biol Chem 293:13100–13111. https://doi.org/10.1074/jbc.RA118.002275
Esler WP, Wolfe MS (2001) A portrait of Alzheimer secretases--new features and familiar faces. Science (80-) 293:1449–1454. https://doi.org/10.1126/science.1064638
Farooqui AA (2016) Therapeutic potentials of curcumin for Alzheimer disease. Springer, Cham
Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG (2015) Soluble amyloid-Î2 oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease. Front Cell Neurosci 9:191. https://doi.org/10.3389/fncel.2015.00191
Fukumoto H, Cheung BS, Hyman BT, Irizarry MC (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59:1381–1389
Gabbita SP, Lovell MA, Markesbery WR (1998) Increased nuclear DNA oxidation in the brain in Alzheimer’s disease. J Neurochem 71:2034–2040
Gamblin TC, King ME, Kuret J et al (2000) Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry 39:14203–14210
Gella A, Durany N (2009) Oxidative stress in Alzheimer disease. Cell Adhes Migr 3:88–93
Gendron TF, Petrucelli L (2009) The role of tau in neurodegeneration. Mol Neurodegener 4:13. https://doi.org/10.1186/1750-1326-4-13
Gkogkolou P, Böhm M (2012) Advanced glycation end products. Dermato-Endocrinology 4:259–270. https://doi.org/10.4161/derm.22028
González C, Farías G, Maccioni RB (1998) Modification of tau to an Alzheimer’s type protein interferes with its interaction with microtubules. Cell Mol Biol (Noisy-le-grand) 44:1117–1127
Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301L Tau transgenic mice induced by Abeta 42 fibrils. Science (80-) 293:1491–1495. https://doi.org/10.1126/science.1062097
Gravina SA, Ho L, Eckman CB et al (1995) Amyloid beta protein (A beta) in Alzheimer’s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem 270:7013–7016
Gsell W, Strein I, Riederer P (1996) The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared. J Neural Transm Suppl 47:73–101
Hagino N, Kobayashi S (2018) Mind in Aging – Nobuyoshi Hagino, Shinjiro Kobayashi – Google Books. https://books.google.com.bd/books?hl=en&lr=&id=RoO9DgAAQBAJ&oi=fnd&pg=PP1&dq=N.+Hagino,+S.+Kobayashi,+Mind+in+Aging.+Scientific+Research+Publishing,+Inc.+(USA,+2017).&ots=U4wit92ivJ&sig=NuiTXLdWzjA1iVYNa_x0kwK2VPA&redir_esc=y#v=onepage&q=N. Hagino%2C. Accessed 14 Nov 2018
Harilal S, Jose J, Parambi DGT, Kumar R, Mathew GE, Uddin MS et al (2019) Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives. J Pharm Pharmacol. https://doi.org/10.1111/jphp.13132
Hesse L, Beher D, Masters CL, Multhaup G (1994) The βA4 amyloid precursor protein binding to copper. FEBS Lett 349:109–116. https://doi.org/10.1016/0014-5793(94)00658-X
Hirai K, Aliev G, Nunomura A et al (2001) Mitochondrial abnormalities in Alzheimer’s disease. J Neurosci 21:3017–3023
Hossain MF, Uddin MS, Uddin GMS et al (2019) Melatonin in Alzheimer’s disease: a latent endogenous regulator of neurogenesis to mitigate Alzheimer’s neuropathology. Mol Neurobiol. https://doi.org/10.1007/s12035-019-01660-3
Hsiao K, Chapman P, Nilsen S et al (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99–102
Huang X, Cuajungco MP, Atwood CS et al (1999a) Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 274:37111–37116
Huang X, Atwood CS, Hartshorn MA et al (1999b) The Aβ peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38:7609–7616. https://doi.org/10.1021/bi990438f
Jongbloed W, Bruggink KA, Kester MI et al (2015) Amyloid-β oligomers relate to cognitive decline in Alzheimer’s disease. J Alzheimers Dis 45:35–43. https://doi.org/10.3233/JAD-142136
Kasapoglu M, Ozben T (2001) Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Gerontol 36:209–220
Keller JN, Pang Z, Geddes JW et al (1997) Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 69:273–284
Kenche VB, Barnham KJ (2011) Alzheimer’s disease & metals: therapeutic opportunities. Br J Pharmacol 163:211–219. https://doi.org/10.1111/j.1476-5381.2011.01221.x
Kish SJ, Mastrogiacomo F, Guttman M et al (1999) Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer’s disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change? J Neurochem 72:700–707
Klein JA, Ackerman SL (2003) Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest 111:785–793. https://doi.org/10.1172/JCI18182
Korolainen MA, Nyman TA, Nyyssonen P et al (2007) Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease. Clin Chem 53:657–665. https://doi.org/10.1373/clinchem.2006.078014
Kosik KS, Shimura H (2005) Phosphorylated tau and the neurodegenerative foldopathies. Biochim Biophys Acta Mol basis Dis 1739:298–310. https://doi.org/10.1016/J.BBADIS.2004.10.011
Kumar R, Atamna H (2011) Therapeutic approaches to delay the onset of Alzheimer’s disease. J Aging Res 2011:1–11. https://doi.org/10.4061/2011/820903
Lagalwar S, Guillozet-Bongaarts AL, Berry RW, Binder LI (2006) Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease. J Neuropathol Exp Neurol 65:455–464. https://doi.org/10.1097/01.jnen.0000229236.98124.d8
Ledesma MD, Pérez M, Colaco C, Avila J (1998) Tau glycation is involved in aggregation of the protein but not in the formation of filaments. Cell Mol Biol (Noisy-le-grand) 44:1111–1116
Li YM, Dickson DW (1997) Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer’s disease. Neurosci Lett 226:155–158
Li H, Li F, Sun H, Qian ZM (2003) Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter. Biochem J 372:757–766. https://doi.org/10.1042/BJ20030075
Li F, Calingasan NY, Yu F et al (2004) Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 89:1308–1312. https://doi.org/10.1111/j.1471-4159.2004.02455.x
Lim GP, Chu T, Yang F et al (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21:8370–8377
Liu Z, Zhou T, Ziegler AC et al (2017) Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxidative Med Cell Longev 2017:1–11. https://doi.org/10.1155/2017/2525967
Loske C, Gerdemann A, Schepl W et al (2000) Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide. Eur J Biochem 267:4171–4178
Lovell MA, Markesbery WR (2007) Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer’s disease. Nucleic Acids Res 35:7497–7504. https://doi.org/10.1093/nar/gkm821
Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease. Neurology 45:1594–1601
Lovell MA, Robertson JD, Teesdale WJ et al (1998) Copper, iron and zinc in Alzheimer’s disease senile plaques. J Neurol Sci 158:47–52
Luo Y, Sunderland T, Roth GS, Wolozin B (1996) Physiological levels of beta-amyloid peptide promote PC12 cell proliferation. Neurosci Lett 217:125–128
Lynch T, Cherny RA, Bush AI (2000) Oxidative processes in Alzheimer’s disease: the role of abeta-metal interactions. Exp Gerontol 35:445–451
Manczak M, Anekonda TS, Henson E et al (2006) Mitochondria are a direct site of Aβ accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15:1437–1449. https://doi.org/10.1093/hmg/ddl066
Mao P, Reddy PH (2011) Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer’s disease: implications for early intervention and therapeutics. Biochim Biophys Acta Mol basis Dis 1812:1359–1370. https://doi.org/10.1016/j.bbadis.2011.08.005
Marcus DL, Thomas C, Rodriguez C et al (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer’s Disease. Exp Neurol 150:40–44. https://doi.org/10.1006/exnr.1997.6750
Mark RJ, Lovell MA, Markesbery WR et al (1997) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 68:255–264
Markesbery WR, Lovell MA (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer’s disease. Neurobiol Aging 19:33–36
Matsuoka Y, Picciano M, La Francois J, Duff K (2001) Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer’s disease. Neuroscience 104:609–613. https://doi.org/10.1016/S0306-4522(01)00115-4
Mattson MP (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77:1081–1132. https://doi.org/10.1152/physrev.1997.77.4.1081
Mattson MP, Chan SL (2003) Neuronal and glial calcium signaling in Alzheimer’s disease. Cell Calcium 34:385–397
Mattson MP, Carney JW, Butterfield DA (1995) A tombstone in Alzheimer’s? Nature 373:481–481. https://doi.org/10.1038/373481a0
Maynard CJ, Cappai R, Volitakis I et al (2002) Overexpression of Alzheimer’s disease amyloid-β opposes the age-dependent elevations of brain copper and iron. J Biol Chem 277:44670–44676. https://doi.org/10.1074/jbc.M204379200
Maynard CJ, Bush AI, Masters CL et al (2005) Metals and amyloid-β in Alzheimer’s disease. Int J Exp Pathol 86:147–159. https://doi.org/10.1111/j.0959-9673.2005.00434.x
Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann Neurol 36:747–751. https://doi.org/10.1002/ana.410360510
Melov S, Adlard PA, Morten K et al (2007) Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2:e536. https://doi.org/10.1371/journal.pone.0000536
Moreira PI, Nunomura A, Nakamura M et al (2008) Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med 44:1493–1505. https://doi.org/10.1016/j.freeradbiomed.2008.01.002
Moreira PI, Carvalho C, Zhu X et al (2010) Mitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiology. Biochim Biophys Acta Mol basis Dis 1802:2–10. https://doi.org/10.1016/j.bbadis.2009.10.006
Münch G, Cunningham AM, Riederer P, Braak E (1998) Advanced glycation end products are associated with Hirano bodies in Alzheimer’s disease. Brain Res 796:307–310
Murakami K, Murata N, Noda Y et al (2011) SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem 286:44557–44568. https://doi.org/10.1074/jbc.M111.279208
Mutisya EM, Bowling AC, Beal MF (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer’s disease. J Neurochem 63:2179–2184
Nisbet RM, Polanco J-C, Ittner LM, Götz J (2015) Tau aggregation and its interplay with amyloid-β. Acta Neuropathol 129:207–220. https://doi.org/10.1007/s00401-014-1371-2
Nishida Y, Yokota T, Takahashi T et al (2006) Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem Biophys Res Commun 350:530–536. https://doi.org/10.1016/j.bbrc.2006.09.083
Nunomura A, Perry G, Pappolla MA et al (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease. J Neurosci 19:1959–1964
Nunomura A, Perry G, Aliev G et al (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759–767
Nunomura A, Chiba S, Lippa CF et al (2004) Neuronal RNA oxidation is a prominent feature of familial Alzheimer’s disease. Neurobiol Dis 17:108–113. https://doi.org/10.1016/j.nbd.2004.06.003
Nunomura A, Tamaoki T, Tanaka K et al (2010) Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiol Dis 37:731–737. https://doi.org/10.1016/j.nbd.2009.12.012
Oda A, Tamaoka A, Araki W (2009) Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells. J Neurosci Res 88. https://doi.org/10.1002/jnr.22271
Onyango IG, Dennis J, Khan SM (2016) Mitochondrial dysfunction in Alzheimer’s disease and the rationale for bioenergetics based therapies. Aging Dis 7:201. https://doi.org/10.14336/AD.2015.1007
Opazo C, Huang X, Cherny RA et al (2002) Metalloenzyme-like activity of Alzheimer’s disease β-amyloid. J Biol Chem 277:40302–40308. https://doi.org/10.1074/jbc.M206428200
Ortwerth BJ, Olesen PR (1988) Ascorbic acid-induced crosslinking of lens proteins: evidence supporting a Maillard reaction. Biochim Biophys Acta Protein Struct Mol Enzymol 956:10–22. https://doi.org/10.1016/0167-4838(88)90292-0
Oshiro S, Kawahara M, Kuroda Y et al (2000) Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells. Biochim Biophys Acta Mol basis Dis 1502:405–414. https://doi.org/10.1016/S0925-4439(00)00065-X
Padurariu M, Ciobica A, Hritcu L et al (2010) Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer’s disease. Neurosci Lett 469:6–10. https://doi.org/10.1016/j.neulet.2009.11.033
Pavlov PF, Petersen CH, Glaser E, Ankarcrona M (2009) Mitochondrial accumulation of APP and Aβ: significance for Alzheimer disease pathogenesis. J Cell Mol Med 13:4137–4145. https://doi.org/10.1111/j.1582-4934.2009.00892.x
Petersen JD, Kaech S, Banker G (2014) Selective microtubule-based transport of dendritic membrane proteins arises in concert with axon specification. J Neurosci 34:4135–4147. https://doi.org/10.1523/JNEUROSCI.3779-13.2014
Plant LD, Boyle JP, Smith IF et al (2003) The production of amyloid beta peptide is a critical requirement for the viability of central neurons. J Neurosci 23:5531–5535
Prabhakaram M, Ortwerth BJ (1994) Determination of glycation crosslinking by the sugar-dependent incorporation of [14C]Lysine into protein. Anal Biochem 216:305–312. https://doi.org/10.1006/abio.1994.1046
Praticò D (2008) Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal. Trends Pharmacol Sci 29:609–615. https://doi.org/10.1016/j.tips.2008.09.001
Praticò D, Sung S (2004) Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer’s disease. J Alzheimers Dis 6:171–175
Quiroz-Baez R, Rojas E, Arias C (2009) Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of α-, β- and γ-secretase expression. Neurochem Int 55:662–670. https://doi.org/10.1016/j.neuint.2009.06.012
Rahman A, Haque A, Uddin MS et al (2017) In Vitro screening for antioxidant and anticholinesterase effects of Uvaria littoralis Blume: a nootropic phytotherapeutic remedy. J Intellect Disabil – Diagnosis Treat 5:50–60. https://doi.org/10.6000/2292-2598.2017.05.02.3
Rhein V, Song X, Wiesner A et al (2009) Amyloid- and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice. Proc Natl Acad Sci 106:20057–20062. https://doi.org/10.1073/pnas.0905529106
Roberson ED, Mucke L (2006) 100 years and counting: prospects for defeating Alzheimer’s disease. Science (80-) 314:781–784. https://doi.org/10.1126/science.1132813
Rodrigues CMP, Solá S, Brito MA et al (2001) Amyloid β-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. Biochem Biophys Res Commun 281:468–474. https://doi.org/10.1006/bbrc.2001.4370
Rottkamp CA, Raina AK, Zhu X et al (2001) Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med 30:447–450
Rousset S, Alves-Guerra M-C, Mozo J et al (2004) The biology of mitochondrial uncoupling proteins. Diabetes 53(Suppl 1):S130–S135
Sambamurti K, Kinsey R, Maloney B et al (2004) Gene structure and organization of the human β-secretase (BACE) promoter. FASEB J 18:1034–1036. https://doi.org/10.1096/fj.03-1378fje
Sayre LM, Moreira PI, Smith MA, Perry G (2005) Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita 41:143–164
Sayre LM, Perry G, Smith MA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21:172–188. https://doi.org/10.1021/tx700210j
Schipper HM, Song W, Zukor H et al (2009) Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 110:469–485. https://doi.org/10.1111/j.1471-4159.2009.06160.x
Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189. https://doi.org/10.1101/cshperspect.a006189
Shen C, Chen Y, Liu H et al (2008) Hydrogen peroxide promotes Abeta production through JNK-dependent activation of gamma-secretase. J Biol Chem 283:17721–17730. https://doi.org/10.1074/jbc.M800013200
Smith MA, Kutty RK, Richey PL et al (1994) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer’s disease. Am J Pathol 145:42–47
Smith MA, Sayre LM, Monnier VM, Perry G (1995) Radical AGEing in Alzheimer’s disease. Trends Neurosci 18:172–176
Smith MA, Perry G, Richey PL et al (1996) Oxidative damage in Alzheimer’s. Nature 382:120–121. https://doi.org/10.1038/382120b0
Smith MA, Sayre LM, Anderson VE et al (1998) Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. J Histochem Cytochem 46:731–735. https://doi.org/10.1177/002215549804600605
Smith MA, Rottkamp CA, Nunomura A et al (2000) Oxidative stress in Alzheimer’s disease. Biochim Biophys Acta 1502:139–144
Stamer K, Vogel R, Thies E et al (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051–1063. https://doi.org/10.1083/jcb.200108057
Steiner H (2004) Uncovering gamma-secretase. Curr Alzheimer Res 1:175–181
Strausak D, Mercer JF, Dieter HH et al (2001) Copper in disorders with neurological symptoms: Alzheimer’s, Menkes, and Wilson diseases. Brain Res Bull 55:175–185
Tamagno E, Guglielmotto M, Aragno M et al (2008) Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J Neurochem 104:683–695. https://doi.org/10.1111/j.1471-4159.2007.05072.x
Uddin MS, Rashid M (2019) Advances in neuropharmacology: drugs and therapeutics. Apple Academic Press, Canada
Uddin MS, Upaganlawar AB (2019) Oxidative stress and antioxidant defense: biomedical value in health and diseases. Nova Science Publishers, USA
Uddin MS, Haque A, Al MA et al (2016) Searching the linkage between high fat diet and Alzheimer′s disease: a debatable proof stand for ketogenic diet to alleviate symptoms of Alzheimer′s patient with APOE ε4 Allele. J Neurol Neurophysiol 07:1–9. https://doi.org/10.4172/2155-9562.1000397
Uddin MS, Al MA, Hossain MS et al (2016a) Neuroprotective effect of Phyllanthus acidus L. on learning and memory impairment in scopolamine-induced animal model of dementia and oxidative stress: natural wonder for regulating the development and progression of Alzheimer’s disease. Adv Alzheimer’s Dis 05:53–72. https://doi.org/10.4236/aad.2016.52005
Uddin MS, Al MA, Hossain MS et al (2016b) Exploring the effect of Phyllanthus emblica L. on cognitive performance, brain antioxidant markers and acetylcholinesterase activity in rats: promising natural gift for the mitigation of Alzheimer’s disease. Ann Neurosci 23:218–229. https://doi.org/10.1159/000449482
Uddin MS, Al MA, Iqbal MA et al (2016c) Analyzing nootropic effect of Phyllanthus reticulatus Poir. on cognitive functions, brain antioxidant enzymes and acetylcholinesterase activity against aluminium-induced Alzheimer’s model in rats: applicable for controlling the risk factors of Alzheimer’s disease. Adv Alzheimer’s Dis 05:87–102. https://doi.org/10.4236/aad.2016.53007
Uddin MS, Nasrullah M, Hossain MS et al (2016d) Evaluation of nootropic activity of Persicaria flaccida on cognitive performance, brain antioxidant markers and acetylcholinesterase activity in rats: implication for the management of Alzheimer’s disease. Am J Psychiatry Neurosci 4(2):26–37. https://doi.org/10.11648/j.ajpn.20160402.12
Uddin MS, Amran MS (2018) Handbook of research on critical examinations of neurodegenerative disorders. Hershey, IGI Global
Uddin MS, Stachowiak A, Al MA et al (2018a) Autophagy and Alzheimer’s disease: from molecular mechanisms to therapeutic implications. Front Aging Neurosci 10:1–18. https://doi.org/10.3389/fnagi.2018.00004
Uddin MS, Al Mamun A, Kabir MT et al (2018b) Nootropic and anti-Alzheimer’s actions of medicinal plants: molecular insight into therapeutic potential to alleviate Alzheimer’s neuropathology. Mol Neurobiol:1–20. https://doi.org/10.1007/s12035-018-1420-2
Uddin MS, Al MA, Labu ZK et al (2019a) Autophagic dysfunction in Alzheimer’s disease: cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis. J Cell Physiol 234(6):8094–8112. https://doi.org/10.1002/jcp.27588
Uddin MS, Kabir MT, Al Mamun A et al (2019b) APOE and Alzheimer’s disease: evidence mounts that targeting APOE4 may combat Alzheimer’s pathogenesis. Mol Neurobiol 56(4):2450–2465. https://doi.org/10.1007/s12035-018-1237-z
Uddin MS, Al MA, Takeda S et al (2019c) Analyzing the chance of developing dementia among geriatric people: a cross-sectional pilot study in Bangladesh. Psychogeriatrics 19(2):87–94. https://doi.org/10.1111/psyg.12368
Vitek MP, Bhattacharya K, Glendening JM et al (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A 91:4766–4770
Walsh DM, Selkoe DJ (2007) Aβ Oligomers – a decade of discovery. J Neurochem 101:1172–1184. https://doi.org/10.1111/j.1471-4159.2006.04426.x
Wan L, Nie G, Zhang J et al (2011) β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease. Free Radic Biol Med 50:122–129. https://doi.org/10.1016/j.freeradbiomed.2010.10.707
Wang X, Wang W, Li L et al (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta Mol basis Dis 1842:1240–1247. https://doi.org/10.1016/j.bbadis.2013.10.015
Weng S-L, Huang K-Y, Kaunang FJ et al (2017) Investigation and identification of protein carbonylation sites based on position-specific amino acid composition and physicochemical features. BMC Bioinf 18:66. https://doi.org/10.1186/s12859-017-1472-8
White AR, Reyes R, Mercer JF et al (1999) Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res 842:439–444
White AR, Barnham KJ, Bush AI (2006) Metal homeostasis in Alzheimer’s disease. Expert Rev Neurother 6:711–722. https://doi.org/10.1586/14737175.6.5.711
Wong CM, Marcocci L, Liu L, Suzuki YJ (2010) Cell signaling by protein carbonylation and decarbonylation. Antioxid Redox Signal 12:393–404. https://doi.org/10.1089/ars.2009.2805
Wright RO, Baccarelli A (2007) Metals and neurotoxicology. J Nutr 137:2809–2813. https://doi.org/10.1093/jn/137.12.2809
Wu Z, Zhang J, Zhao B (2009) Superoxide anion regulates the mitochondrial free Ca 2+ through uncoupling proteins. Antioxid Redox Signal 11:1805–1818. https://doi.org/10.1089/ars.2009.2427
Wu Z, Zhao Y, Zhao B (2010) Superoxide anion, uncoupling proteins and Alzheimer’s disease. J Clin Biochem Nutr 46:187–194. https://doi.org/10.3164/jcbn.09-104-2
Xiao Q, Gil S-C, Yan P et al (2012) Role of phosphatidylinositol Clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. J Biol Chem 287:21279–21289. https://doi.org/10.1074/jbc.M111.338376
Yan SD, Chen X, Schmidt AM et al (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci U S A 91:7787–7791
Yang L-B, Lindholm K, Yan R et al (2003) Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9:3–4. https://doi.org/10.1038/nm0103-3
Yankner BA, Lu T (2009) Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem 284:4755–4759. https://doi.org/10.1074/jbc.R800018200
Yao M, Nguyen T-V V, Pike CJ (2005) Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci 25:1149–1158. https://doi.org/10.1523/JNEUROSCI.4736-04.2005
Yoo M-H, Gu X, Xu X-M et al (2010) Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer’s disease. Antioxid Redox Signal 12:819–827. https://doi.org/10.1089/ars.2009.2891
Yoshiyama Y, Higuchi M, Zhang B et al (2007) Synapse loss and microglial activation precede tangles in a P301S Tauopathy mouse model. Neuron 53:337–351. https://doi.org/10.1016/j.neuron.2007.01.010
Younessi P, Yoonessi A (2011) Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress. Iran J Med Sci 36:154–166
Zaplatic E, Bule M, Shah SZA, Uddin MS et al (2019) Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer’s disease. Life Sci 224:109–119. https://doi.org/10.1016/j.lfs.2019.03.055
Zhang J, Liu Q, Chen Q et al (2006) Nicotine attenuates β-amyloid-induced neurotoxicity by regulating metal homeostasis. FASEB J 20:1212–1214. https://doi.org/10.1096/fj.05-5214fje
Zhang L-H, Wang X, Stoltenberg M et al (2008) Abundant expression of zinc transporters in the amyloid plaques of Alzheimer’s disease brain. Brain Res Bull 77:55–60. https://doi.org/10.1016/j.brainresbull.2008.03.014
Zhang L-H, Wang X, Zheng Z-H et al (2010) Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain. Neurobiol Aging 31:74–87. https://doi.org/10.1016/j.neurobiolaging.2008.02.018
Zhang Y, Li P, Feng J, Wu M (2016) Dysfunction of NMDA receptors in Alzheimer’s disease. Neurol Sci 37:1039–1047. https://doi.org/10.1007/s10072-016-2546-5
Zhao Y, Zhao B (2012) Natural antioxidants in prevention and management of Alzheimer’s disease. Front Biosci (Elite Ed) 4:794–808
Zheng W-H, Bastianetto S, Mennicken F et al (2002) Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 115:201–211
Zheng W, Xin N, Chi Z-H et al (2009) Divalent metal transporter 1 is involved in amyloid precursor protein processing and Aβ generation. FASEB J 23:4207–4217. https://doi.org/10.1096/fj.09-135749
Zhou Q, Lam PY, Han D, Cadenas E (2009) Activation of c-Jun-N-terminal kinase and decline of mitochondrial pyruvate dehydrogenase activity during brain aging. FEBS Lett 583:1132–1140. https://doi.org/10.1016/j.febslet.2009.02.043
Zhu X, Raina AK, Rottkamp CA et al (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer’s disease. J Neurochem 76:435–441
Zhu X, Raina AK, Perry G, Smith MA (2004) Alzheimer’s disease: the two-hit hypothesis. Lancet Neurol 3:219–226. https://doi.org/10.1016/S1474-4422(04)00707-0
Zhu X, Perry G, Moreira PI et al (2006) Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J Alzheimers Dis 9:147–153
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Uddin, M.S., Kabir, M.T. (2019). Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability. In: Ashraf, G., Alexiou, A. (eds) Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease. Springer, Singapore. https://doi.org/10.1007/978-981-13-9636-6_5
Download citation
DOI: https://doi.org/10.1007/978-981-13-9636-6_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9635-9
Online ISBN: 978-981-13-9636-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)